Winston Pharmaceuticals, Inc. (WPHM)

Market Cap	7.74K -99.9%
Revenue (ttm)	1.37M +92.4%
Net Income	-2.34M
EPS	-0.03
Shares Out	77.41M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	400
Average Volume	8,293
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.0001 - 0.0001
Beta	-1,365.37
RSI	n/a
Earnings Date	n/a

About Winston Pharmaceuticals

Winston Pharmaceuticals, Inc., a pharmaceutical company, discovers, develops, and commercializes therapeutics for pain management. It focuses on pain indications, such as episodic cluster headache, chronic migraine headache, neuropathic pain syndromes, osteo-and rheumatoid arthritis, and pain and inflammation in inflammatory bowel disease, as well as niche indications. Winston Pharmaceuticals, Inc. was formerly known as Winston Laboratories, Inc. and changed its name to Winston Pharmaceuticals, Inc. in November 2008. The company was incorporate...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 9
• Stock Exchange: OTCMKTS
• Ticker Symbol: WPHM

Financial Performance

In 2009, Winston Pharmaceuticals's revenue was $1.39 million, an increase of 208.17% compared to the previous year's $452,542. Losses were -$2.66 million, -48.36% less than in 2008.